£568k
+16%vs Dec 2023Active11672637Private limited companyCobham
NAD+ LABS LTD
Significant control: Santos Hold Co Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nad+ Labs Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Nad+ Labs Ltd sell?
Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NAD+ LABS LTD is an active private limited company (company number 11672637) incorporated on 12 November 2018, registered in Cobham. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 31 December 2024, showing net assets of £568k and cash of £13k, with 1 employee on average. Net assets rose 16% on the prior period (£488k).
Peer position · net assets
By net assets it sits in the top quarter of 6,105 comparable companies in Greater London (median £2,394, upper quartile £21k).
02
Ownership and control
- Santos Hold Co Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Ms Kayleigh Louise Santos
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 November 20187 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 26 November 2026in 32 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£13k
−18%vs Dec 2023Not reported
1
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £568k | £13k | £213k | £487k | — | — | 1 |
| 31 December 2023 | £488k | £16k | £103k | £439k | — | — | 1 |
Current ratio0.57Current assets ÷ creditors within one year
Cash per employee£13kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £568,261 at 31 December 2024
- Net assets up 10% or more on the prior period+16.4% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.57
- Incorporated five or more years agoIncorporated 12 November 2018
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 32 days
- Next accounts due25 days overdue
- Accounts period endNet assets £568k · small accounts
- Accounts period endNet assets £488k · small accounts
- Incorporated
08
Similar companies in Greater London
- TUATARA CYPCN TRAINING LIMITEDWatford · inc. Nov 2018
- JJ ASSOCIATES LTDOrpington · inc. Nov 2018
- GRAYDA LTDIlford · inc. Nov 2018
- LONDON HARLEY CLINIC LIMITEDIlford · inc. Nov 2018
- ORMI HEALTHCARE LTDGrays · inc. Nov 2018
- OMER OPTOMETRIC SERVICES LTDIlford · inc. Nov 2018
All companies incorporated on 12 November 2018 · in Nov 2018.
09
Reminders for NAD+ LABS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.